Bertuccini Lucia, et al.
International journal of immunopathology and pharmacology, 2017
Abstract
The human vagina is colonized by a variety of microbes. Lactobacilli are the most common, mainly in healthy women; however, the microbiota composition can change rapidly, leading to infection or to a state in which potential pathogenic microorganisms co-exist with other commensals. In premenopausal women, urogenital infections, such as bacterial vaginosis and aerobic vaginitis, remain an important health problem. Treatment of these infections involves different kind of antibiotics; however, the recurrence rate remains high, and it must be also underlined that antibiotics are unable to spontaneously restore normal flora characterized by an abundant community of Lactobacilli. The main limitation is the inability to offer a long-term defensive barrier, thus facilitating relapses and recurrences. We report here the antimicrobial activities of two commercially existing Lactobacillus strains, Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus GLA-14 strains and their combination (Respecta® probiotic blend) against four different pathogens responsible for both bacterial vaginosis ( Gardenerella vaginalis and Atopobium vaginae) and aerobic vaginitis ( Staphylococcus aureus and Escherichia coli) by co-culturing assay. The probiotic combination, even if resulting in a different microbicidal activity against the different strains tested, demonstrated the efficacy of combined Lactobacillus strain treatment.
Keywords
Lactobacillus; aerobic vaginitis; antimicrobial; bacterial vaginosis.
Conflict of interest statement
Declaration of conflicting interests: The authors declared the following conflicts of interest with respect to the research, authorship, and/or publication of this article: RR is an employee of Giellepi S.p.A.| PMID: | 28580872 |
|---|---|
| DOI: | 10.1177/0394632017697987 |
| PMCID (Free PMC Article): | PMC5806794 |
| Category: | Women's Health |
The best supplements with Lactobacillus Rhamnosus or Lactobacillus Acidophilus in Women's Health category:
- Woman's Probiotic 20 Billion, 50 Veggie Caps (Now Foods) - Now Women's Probiotic has been specially formulated using three clinically tested probiotic strains to support women's health through every stage of life. It contains among others: Lactobacillus Rhamnosus, Lactobacillus Acidophilus.
Articles similar to "Effects of Lactobacillus Rhamnosus and Lactobacillus Acidophilus on Bacterial Vaginal Pathogens."
- The impact of Lactobacillus Acidophilus on Women's Health: Effects of Probiotics on the Recurrence of Bacterial Vaginosis: A Review. (Objective: Bacterial vaginosis (BV) is a common cause of genital discomfort in women in reproductive ages, which causes many complications... Although the results of different studies are controversial, most studies have been in favor of the probiotics in the prevention or treatment of BV, and no adverse effects have been reported. Therefore, it may be helpful to recommend daily consumption of probiotic products to improve public health among women.)
- The role of Lactobacillus Rhamnosus in Women's Health: Long-term Lactobacillus Rhamnosus BMX 54 Application to Restore a Balanced Vaginal Ecosystem: A Promising Solution Against HPV-infection. ( Over recent years, a growing interest has developed in microbiota and in the concept of maintaining a special balance between Lactobacillus and other bacteria species in order to promote women's well-being... The consistent percentage of clearance of PAP-smear abnormalities and HPV-clearance obtained in long-term treatment group has been interestingly high and encouraging. Obviously, larger and randomized studies are warranted to confirm these encouraging results, but we believe that eubiosis re-establishment is the key to tackle effectively even HPV-infection. )
- The impact of Lactobacillus Rhamnosus on Women's Health: Probiotics in the Prevention of Recurrences of Bacterial Vaginosis. (Context: Bacterial vaginosis (BV) is the most common cause of vaginal discharge in women during their fertile years...)
- The significance of Lactobacillus Rhamnosus for Women's Health: Effect of a Yoghurt Drink Containing Lactobacillus Strains on Bacterial Vaginosis in Women - A Double-Blind, Randomised, Controlled Clinical Pilot Trial. (Bacterial vaginosis (BV) is characterised by a depletion of lactobacilli in favour of an overgrowth of anaerobic bacteria...)
- The impact of Lactobacillus Rhamnosus on Women's Health: Restoring Vaginal Microbiota: Biological Control of Bacterial Vaginosis. A Prospective Case-Control Study Using Lactobacillus Rhamnosus BMX 54 as Adjuvant Treatment Against Bacterial Vaginosis. (Purpose: Bacterial vaginosis (BV) is the most prevalent lower genital tract infection in reproductive-age women worldwide... Probiotic supplementation with vaginal Lactobacillus rhamnosus BMX54 seems to be useful in hindering bacteria growth especially after antibiotic therapy; therefore this intervention may be considered a new prophylactic treatment for preventing recurrence of BV, in particular in high-risk patients. )
- The role of Lactobacillus Acidophilus in Women's Health: Evidence-based Mixture Containing Lactobacillus Strains and Lactoferrin to Prevent Recurrent Bacterial Vaginosis: A Double Blind, Placebo Controlled, Randomised Clinical Trial. (Bacterial vaginosis (BV) is the most common cause of vaginal discomfort in women... Probiotic supplementation with vaginal Lactobacillus rhamnosus BMX54 seems to be useful in hindering bacteria growth especially after antibiotic therapy; therefore this intervention may be considered a new prophylactic treatment for preventing recurrence of BV, in particular in high-risk patients. )
- The role of Lactobacillus Rhamnosus in Women's Health: Effectiveness of Vaginal Administration of Lactobacillus Rhamnosus Following Conventional Metronidazole Therapy: How to Lower the Rate of Bacterial Vaginosis Recurrences. (Eighty-four patients with bacterial vaginosis diagnosed according to Amsel's criteria were randomized to receive either oral metronidazole 500 mg twice a day for seven days, or one vaginal tablet containing freeze-dried Lactobacillus rhamnosus once a week at bedtime for two months starting one week after the last antibiotic administration... Probiotic supplementation with vaginal Lactobacillus rhamnosus BMX54 seems to be useful in hindering bacteria growth especially after antibiotic therapy; therefore this intervention may be considered a new prophylactic treatment for preventing recurrence of BV, in particular in high-risk patients. )